- Home
- KYTX vs EDF Comparison
KYTX vs EDF Comparison
Compare KYTX & EDF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KYTX
- EDF
- Stock Information
- Founded
- KYTX 2018
- EDF 2010
- Country
- KYTX United States
- EDF United States
- Employees
- KYTX N/A
- EDF N/A
- Industry
- KYTX
- EDF Investment Managers
- Sector
- KYTX
- EDF Finance
- Exchange
- KYTX NYSE
- EDF Nasdaq
- Market Cap
- KYTX 130.8M
- EDF 148.8M
- IPO Year
- KYTX 2024
- EDF N/A
- Fundamental
- Price
- KYTX $2.78
- EDF $5.25
- Analyst Decision
- KYTX Buy
- EDF
- Analyst Count
- KYTX 5
- EDF 0
- Target Price
- KYTX $23.20
- EDF N/A
- AVG Volume (30 Days)
- KYTX 468.8K
- EDF 160.6K
- Earning Date
- KYTX 03-04-2025
- EDF 01-01-0001
- Dividend Yield
- KYTX N/A
- EDF 13.14%
- EPS Growth
- KYTX N/A
- EDF N/A
- EPS
- KYTX N/A
- EDF N/A
- Revenue
- KYTX N/A
- EDF N/A
- Revenue This Year
- KYTX N/A
- EDF N/A
- Revenue Next Year
- KYTX N/A
- EDF N/A
- P/E Ratio
- KYTX N/A
- EDF N/A
- Revenue Growth
- KYTX N/A
- EDF N/A
- 52 Week Low
- KYTX $2.65
- EDF $3.51
- 52 Week High
- KYTX $30.60
- EDF $5.50
- Technical
- Relative Strength Index (RSI)
- KYTX 36.42
- EDF 65.47
- Support Level
- KYTX $2.65
- EDF $5.00
- Resistance Level
- KYTX $3.11
- EDF $5.19
- Average True Range (ATR)
- KYTX 0.22
- EDF 0.08
- MACD
- KYTX 0.01
- EDF 0.00
- Stochastic Oscillator
- KYTX 17.88
- EDF 89.29
About KYTX KYVERNA THERAPEUTICS INC
Kyverna Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on developing cell therapies for patients suffering from autoimmune diseases. Its product KYV-101, is an autologous CD19 CAR T-cell product candidate made from an underlying chimeric antigen receptor, or CAR. It is also developing KYV-201, an allogeneic therapy containing the same CAR as KYV-101, to develop it in multiple autoimmune diseases.
About EDF Virtus Stone Harbor Emerging Markets Income Fund of Beneficial Interest
Virtus Stone Harbor Emerging Markets Income Fund is a closed-end management investment company. Its investment objective is to maximize total return, which consists of income from its investments and capital appreciation. The Fund normally will invest at least 80% of its net assets (plus any borrowings for investment purposes) in emerging markets securities.